FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely traumatology and surgery, and may be used for bleeding control. That is ensured by the use of a composition, as well as an adhesive material containing gelatin and transglutaminase wherein their relation is sufficient for bleeding control in a wound, and wherein said gelatin is not exposed to irreversible gel-formation and forms a solution with transglutaminase at temperature below natural one of a gel-sol junction of standard animal gelatin prepared from an animal source or representing recombinant gelatin or their combination.
EFFECT: use of the given inventions enables reducing time of bleeding control in the wound.
22 cl, 15 dwg, 12 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR LOCAL HAEMOSTASIS IN EXPLOSIVE WOUND | 2014 |
|
RU2583138C2 |
| CRUSHED POLYMERIC HYDROGELS FOR PREVENTION OF COMMISSURE FORMATION AND METHODS FOR THEIR PREPARING | 1997 |
|
RU2207882C2 |
| COASERVATE CAPSULES WITH SOLID NUCLEUS | 2011 |
|
RU2636510C2 |
| HAEMOSTATIC PREPARATION CONTAINING EXTRACT OF GOLDEN MOSS | 2011 |
|
RU2581918C2 |
| MULTILAYER COMBINED LOCAL HAEMOSTATIC AGENT | 2023 |
|
RU2826069C1 |
| HYDROGEL PRECURSOR COMPOSITION AND USE THEREOF | 2017 |
|
RU2770445C2 |
| HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
| METHOD FOR PRODUCTION OF PROTEIN-POLYSACCHARIDE BIODEGRADABLE FILM | 2015 |
|
RU2604223C1 |
| HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
| PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING POLOXAMER | 2009 |
|
RU2482874C2 |
